Full name
CENTRAL EUROPE GENOMICS CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CENTRAL EUROPE GENOMICS CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. WARSZAWSKA 6 / 32, 15-063 BIAŁYSTOK
TAX ID9721257627
Rate company:
CENTRAL EUROPE GENOMICS CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9721257627
KRS0000577544
Share capital6,800.00 zł
address
UL. WARSZAWSKA 6 / 32, 15-063 BIAŁYSTOK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9721257627
REGON
362578230
KRS
0000577544
Legal form
limited liability company
Register Address
UL. WARSZAWSKA 6 / 32, 15-063 BIAŁYSTOK
Date of registration in KRS
2015-09-28
Date of commencement of economic activity
2015-09-28
Act signature
RDF/576818/24/892
Pkd codes
72.11.Z - Research and experimental development on biotechnology
58.1 - Publishing of books, periodicals and other publishing activities
58.2 - Software publishing
62.0 - Computer programming, consultancy and related activities
63.1 - Data processing, hosting and related activities; web portals
63.9 - Other information service activities
71.1 - Architectural and engineering activities and related technical consultancy
71.2 - Technical testing and analysis
73.1 - Advertising
74.9 - Other professional, scientific and technical activities not elsewhere classified
Payer VAT status
Unregirestered
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | ||
|---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss)  | 0,6 | 1,4 | 140,6 |
EBITDA | 0,6 | 2,1 | 249,5 |
Short time liabilities | 6,7 | 7,2 | 7,7 |
Equity capital | 0,6 | 1,9 | 221,9 |
Operating profit (EBIT) | 0,6 | 2,1 | 249,5 |
Assets | 7,3 | 9,1 | 25 |
Net profit (loss) | 0,6 | 1,2 | 109,2 |
Cash | 2,3 | 0,7 | -69,6 |
Net income from sale | 4,6 | 7,5 | 61,5 |
Liabilities and provisions for liabilities | 6,7 | 7,2 | 7,7 |
Working assets | 4,1 | 5,9 | 44,2 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 100,9 | 65,5 | -35,4 |
Equity capital to total assets | 8,1 | 20,8 | 12,7 |
Gross profit margin | 12,8 | 19,1 | 6,3 |
EBITDA Margin | 13 | 28,2 | 15,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 528 | 352 | -176 |
Current financial liquidity indicator | 0.6152769923210144 | 0.8233811855316162 | 0,2 |
Net dept to EBITDA | -3.7784671783447266 | 0.7075936198234558 | 4,5 |
Financial statements
01-01-2021 - 31-12-2021
Annual financial report
Download xml01-01-2021 - 31-12-2021
Annual financial report
Download doc01-01-2021 - 31-12-2021
Resolution or decision approving the annual financial statements
Download pdf01-01-2021 - 31-12-2021
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
MR GREEN DOMINIK STATKIEWICZ
Szczecin
LIFESPAN MOLECULES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
BIELANY WROCŁAWSKIE
Michał Ordak Ekspertstat
Warszawa